Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nursing Clinical Information System01:27

Nursing Clinical Information System

1.3K
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
1.3K
Clinical Trials01:16

Clinical Trials

10.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.5K
Tissue Transplantation01:24

Tissue Transplantation

1.1K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.1K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.9K
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

451
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
451
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

3.5K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
3.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Amniotic epithelial cells enhance islet engraftment by suppressing early inflammation in intraportal transplantation.

Cell transplantation·2026
Same author

Three-year outcomes of posterior nasal neurectomy for allergic rhinitis: Clinical outcomes by surgical technique with a focus on ENS-related symptoms.

American journal of otolaryngology·2026
Same author

Efficacy of Omalizumab against Japanese Cedar pollinosis in clinical practice.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology·2025
Same author

Coagulation activation and hepatic engraftment of human amnion-derived cells after intraportal transplantation in rats.

Regenerative medicine·2025
Same author

Labeling of mitochondria for detection of intercellular mitochondrial transfer.

Methods in cell biology·2025
Same author

Amniotic epithelial Cell microvesicles uptake inhibits PBMCs and Jurkat cells activation by inducing mitochondria-dependent apoptosis.

iScience·2025

Related Experiment Video

Updated: Feb 2, 2026

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
09:54

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine

Published on: November 4, 2018

8.5K

Clinical hepatocyte transplantation.

Toshio Miki1

  • 1Department of Surgery, Keck School of Medicine, University of Southern California, Los Angeles, United States.

Gastroenterologia Y Hepatologia
|November 25, 2018
PubMed
Summary
This summary is machine-generated.

Hepatocyte transplantation offers a promising alternative for liver disease patients facing organ shortages. This approach complements whole liver replacement, especially for metabolic disorders, advancing cell replacement therapies.

Keywords:
Cell therapyCongenital disordersHepatocitosHepatocytesTerapia celularTrastornos congénitos

More Related Videos

Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice
11:24

Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice

Published on: February 10, 2018

14.8K
Isolation of Regenerating Hepatocytes after Partial Hepatectomy in Mice
10:04

Isolation of Regenerating Hepatocytes after Partial Hepatectomy in Mice

Published on: December 2, 2022

5.6K

Related Experiment Videos

Last Updated: Feb 2, 2026

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
09:54

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine

Published on: November 4, 2018

8.5K
Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice
11:24

Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice

Published on: February 10, 2018

14.8K
Isolation of Regenerating Hepatocytes after Partial Hepatectomy in Mice
10:04

Isolation of Regenerating Hepatocytes after Partial Hepatectomy in Mice

Published on: December 2, 2022

5.6K

Area of Science:

  • Hepatology and Transplantation Biology

Background:

  • Severe shortage of donor organs for liver transplantation worldwide.
  • Hepatocyte transplantation as a potential alternative for liver disease.
  • Addresses unmet medical needs in patients awaiting liver transplants.

Purpose of the Study:

  • Summarize current knowledge and limitations of clinical hepatocyte transplantation.
  • Advance understanding of cell replacement therapies.
  • Improve options for patients on the liver transplant waiting list.

Main Methods:

  • Review of existing literature on hepatocyte transplantation.
  • Analysis of clinical data and outcomes.
  • Identification of current challenges and future directions.

Main Results:

  • Hepatocyte transplantation complements orthotopic liver transplantation (OLT).
  • Particularly beneficial for patients with congenital metabolic disorders not requiring whole liver replacement.
  • Highlights the need for further research and development.

Conclusions:

  • Hepatocyte transplantation is a viable complementary therapy for specific liver conditions.
  • Further advancements are needed to overcome current limitations.
  • Aims to develop novel cell replacement strategies for liver failure patients.